Sulfonic Acid Group Containing (-(o=)s(=o)-oh, Wherein H Of -oh May Be Replaced By A Substituted Or Unsubstituted Ammonium Ion Or Metal) Patents (Class 534/674)
Abstract: Prodrug compounds which metabolize into 5-ASA or analogs thereof, and taurine or analogs thereof, in the colon site are disclosed. Pharmaceutical compositions including the compounds, and methods of treatment using the compounds, are also disclosed. Such compounds have utility for treating or preventing gastrointestinal disorders, including colon cancer, ulcerative colitis and Crohn's disease.
Abstract: Prodrug compounds which metabolize into 5-ASA or analogs thereof, and taurine or analogs thereof, in the colon site are disclosed. Pharmaceutical compositions including the compounds, and methods of treatment using the compounds, are also disclosed. Such compounds have utility for treating or preventing gastrointestinal disorders, including colon cancer, ulcerative colitis and Crohn's disease.
Abstract: Prodrug compounds which metabolize into 5-ASA or analogs thereof, and taurine or analogs thereof, in the colon site are disclosed. Pharmaceutical compositions including the compounds, and methods of treatment using the compounds, are also disclosed. Such compounds have utility for treating or preventing gastrointestinal disorders, including colon cancer, ulcerative colitis and Crohn's disease.
Abstract: A group of compounds comprising the reaction product of a hydroxy naphthylamine sulfonic acid with a diazotized compound comprising, an aromatic azo substituted Cleves Acid such that the diazotized compound is coupled with the hydroxy naphthylamine sulfonic acid ortho to the amine group. More particularly the compounds of the invention comprise a compound having the formula: ##STR1## wherein R.sub.1 is an aromatic azo radical, R.sub.2 is hydrogen or an aromatic azo group and R.sub.3 is amino, substituted amino or an aromatic azo group. The invention further includes inks made from such compositions and methods for using such inks in ink jet printers.
Abstract: The disclosure relates to a method of producing 5-amino salicylic acid from salicylic acid, with sulphanilic acid as the recyclable auxiliary chemical.The method according to the present invention includes linking between the diazonium salt of the sulphanilic acid and the salicylic acid, followed by a splitting by hydrogenation with hydrogen gas and catalyst, and selective precipitation of the desired product.